Annual Drug Patent Expirations for OSENI
Oseni is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from two suppliers. There are five patents protecting this drug.
Drug patent litigation for OSENI.
This drug has one hundred and sixty-two patent family members in forty-five countries.
The generic ingredient in OSENI is alogliptin benzoate; pioglitazone hydrochloride. Two suppliers are listed for this compound. Additional details are available on the alogliptin benzoate; pioglitazone hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
